Toews Corporation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,500
Closed -$962K 79
2020
Q3
$962K Buy
+6,500
New +$1.01M 0.29% 99
2019
Q1
Sell
-8,700
Closed -$1.01M 66
2018
Q4
$1.01M Buy
+8,700
New +$972K 0.44% 51
2018
Q3
Sell
-4,000
Closed -$341K 63
2018
Q2
$341K Buy
+4,000
New +$329K 0.08% 81

Other funds holding LLY

Toews Corporation's LLY Position: Q4 2020 in Review

Toews Corporation sold out of Eli Lilly (LLY) in Q4 2020, closing a stake of 6,500 shares — an estimated $962K sold.

Toews Corporation first reported a position in LLY in Q2 2018 and held it in 3 quarters. The position peaked at $1.01M in Q4 2018. 1,886 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • Toews Corporation reported no remaining Eli Lilly position as of Q4 2020 after selling out during the quarter.
  • Toews Corporation sold 6,500 Eli Lilly shares in Q4 2020, an estimated $962K.
  • Toews Corporation first reported a position in Eli Lilly in Q2 2018 and held it in 3 quarters.
  • Toews Corporation's Eli Lilly position peaked at $1.01M in Q4 2018.
  • 1,886 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Toews Corporation's 13F filing for Q4 2020, filed 3 Feb 2021.